Apoptosis induced by adenosine in human leukemia HL-60 cells. 1994

Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
Department of Biochemistry, Nara Medical University, Japan.

Among several nucleosides and nucleotides, which showed strong inhibition of growth of HL-60 cells, only adenosine (Ado) specifically induced typical apoptotic death of the cells, accompanying double-strand cleavage of DNA into nucleosomal size fragments, and subsequent apoptotic body formation. A marked enhancement of endogenous poly(ADP-ribosyl)ation activity in the cell was detected at a relatively early stage of cell death, whereas other nucleosides and nucleotides tested were ineffective on poly(ADP-ribosyl)ation activity, suggesting that the enzyme activation is closely related to apoptosis. The observed Ado effect was not mediated by Ado receptors, in contrast to the Ado-induced apoptotic death of thymocytes, judging from the facts that all of the receptor agonists tested did not substitute for Ado and that a receptor antagonist did not inhibit the effect of Ado. Ado transport into the cell seemed to be essential for the induction of apoptosis, since an inhibitor of Ado transport (dipyridamole) strongly suppressed apoptosis. Cytochalasin B blocked Ado-induced apoptotic body formation without affecting activation of endogenous poly(ADP-ribosyl)ation activity in the cell. Thus, the process of apoptosis in HL-60 cells induced by Ado seems to be separated into at least two steps, an initial step of DNA degradation and a following morphological change. While the adenine moiety of Ado was essential for its apoptosis-inducing activity, the sugar was replaceable, and various analogs with modified sugar were inducers of apoptosis, although they were less efficient than Ado.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009707 Nucleosomes The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4. Dinucleosomes,Polynucleosomes,Dinucleosome,Nucleosome,Polynucleosome
D011064 Poly Adenosine Diphosphate Ribose A polynucleotide formed from the ADP-RIBOSE moiety of nicotinamide-adenine dinucleotide (NAD) by POLY(ADP-RIBOSE) POLYMERASES. Poly ADP Ribose,Poly(ADP-Ribose),Poly-ADPR,Poly-Adenosine Diphosphate-Ribose,ADP Ribose, Poly,Diphosphate-Ribose, Poly-Adenosine,Poly ADPR,Ribose, Poly ADP
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003070 Coformycin A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.
D003839 Deoxyadenosines Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule. Adenine Deoxyribonucleosides,Adenylyldeoxyribonucleosides,Deoxyadenosine Derivatives,Deoxyribonucleosides, Adenine,Derivatives, Deoxyadenosine
D003849 Deoxyguanosine A nucleoside consisting of the base guanine and the sugar deoxyribose.
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006151 Guanosine A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
March 1999, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
May 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
December 2008, Toxicology letters,
Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
May 2002, Acta pharmacologica Sinica,
Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
January 2004, Biochemical pharmacology,
Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
February 1996, Biochemical and biophysical research communications,
Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
September 2009, Toxicological research,
Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
September 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
July 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Y Tanaka, and K Yoshihara, and M Tsuyuki, and T Kamiya
March 1999, Anti-cancer drugs,
Copied contents to your clipboard!